Gabelli Funds’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,500
Closed -$442K 1103
2019
Q3
$442K Sell
5,500
-2,000
-27% -$161K ﹤0.01% 969
2019
Q2
$544K Buy
+7,500
New +$544K ﹤0.01% 970